Compare the analgesic effect of Erector spinae block and pericapsular nerve block for primary total hip replacement surgery

Comparison of efficacy of Erector spinae block with pericapsular nerve block in patients undergoing primary total hip replacement : A Randomized Controlled Trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/09/045147

Enrollment

Registered

2022-09-01

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M169- Osteoarthritis of hip, unspecified

Interventions

Intervention1: ESP Block: Group A -ESP Block 30 ml 0.2% ropivacaine will be given Control Intervention1: PENG Block: Group B: PENG Block30 ml 0.2% ropivacaine will be given

Eligibility

Inclusion criteria

Inclusion criteria: 1.ASA I/II Patient 2.Adults 18-65 yr 3.Undergoing unilateral total hip arthroplasty through posterior approach

Exclusion criteria

Exclusion criteria: 1.Patient refusal 2.Known neuropathy 3.Pregnancy 4.Infection at the puncture site 5.Chronic analgesic intake 6.Altered coagulation parameters 7.Inability to communicate 8.Redo arthroplasty 9.Morbid obesity(BMI greater than or equal to 40)

Design outcomes

Primary

Measure	Time frame
To assess the total opioid consumption in 24 hoursTimepoint: 24 hours	—

Secondary

Measure	Time frame
1.NRS at various time intervals: (rest and dynamic) 2.To assess the patient satisfaction at the end of surgery Timepoint: 24hrs	—

Countries

India

Contacts

Public ContactDr Chandni Sinha

All India institute of medical sciences-patna

chandni.doc@gmail.com7250333148

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026